Study examines real-world treat-and-extend outcomes and background factors of macular atrophy
Ophthalmology Times Europe,
Investigators retrospectively evaluated treatment-naïve patients who received a loading dose of a minimum of three monthly…
Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes
Ophthalmology Times,
(Image Credit: AdobeStock/sergign) A multicenter study of the outcomes of a treat-and-extend (TAE) regimen using aflibercept (Eyl…
Beyond VEGF: A Next-generation therapies aim to enhance vision and quality of life in neovascular AMD
Ophthalmology Times,
(Image Credit: AdobeStock/RFBSIP) VEGF-A therapy has revolutionized treatment and visual outcomes for patients with neovascular…
New wet AMD therapeutics seek to improve visual outcomes beyond the current standard of care
Ophthalmology Times Europe,
When evaluating a therapy’s durability, it is important to consider that the criteria commonly applied in clinical trials is…